Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Real Winners of $1,000 Exomes
Motley Fool
Saturday, October 1, 2011 - 12:42pm
tags:
23andMe, Google, Illumina, genome sequencing
Agenus Announces Reverse Stock Split
Yahoo/GlobeNewswire
Saturday, October 1, 2011 - 12:39pm
tags:
Agenus
Vical's Allovectin-7: Are The Phase 3 Trial Results Hiding In Plain Sight?
Seeking Alpha
Saturday, October 1, 2011 - 12:36pm
tags:
Vical, Allovectin-7
How Quickly Is the Cash Coming at Illumina?
Motley Fool
Saturday, October 1, 2011 - 12:35pm
tags:
Illumina
Human Genome slides on U.K. setback
MarketWatch
Saturday, October 1, 2011 - 12:34pm
tags:
Human Genome Sciences, lupus, Benlysta
FDA Biosimilar Guidelines Complete, Awaiting Publication
Patent Docs
Friday, September 30, 2011 - 12:20pm
tags:
FDA, biosimilars
Human Genome Sciences stock falls as Britain denies funding for Benlysta
Bizjournals.com
Friday, September 30, 2011 - 12:11pm
tags:
Human Genome Sciences, UK, Benlysta, lupus, GSK
Takeda Completes Acquisition and Names New CEO of Nycomed
PR Newswire
Friday, September 30, 2011 - 12:09pm
tags:
Takeda, Nycomed, M&A
Pfizer, Roche, Novartis lead the way for Big Pharma in Japan
Fierce Pharma
Friday, September 30, 2011 - 12:03pm
tags:
Japan, Pfizer, Roche, Novartis
Pharmasset Shares Surge on New Hep C Data
TheStreet.com
Friday, September 30, 2011 - 12:02pm
tags:
Pharmasset, hepatitis C, PSI-7977
Investors Guide to the New PDUFA
Motley Fool
Friday, September 30, 2011 - 11:16am
tags:
PDUFA, investors
ViroPharma pays Intellect Neurosciences $6.5 million for drug molecule rights
Yahoo/AP
Friday, September 30, 2011 - 11:10am
tags:
ViroPharma, Intellect Neurosciences, Friedreich's Ataxia, OX1
Array says potential lung cancer treatment misses statistical significance in mid-stage trial
Yahoo/AP
Friday, September 30, 2011 - 11:09am
tags:
Array, lung cancer, selumetinib, AstraZeneca
[video] The Next Big Thing In Biotech: Hep C Drugs
TheStreet.com
Friday, September 30, 2011 - 11:07am
tags:
hepatitis C, Inhibitex, Vertex, Indenix, Pharmasset
Add-on depression meds a bright spot in eroding market
Fierce Pharma
Friday, September 30, 2011 - 11:01am
tags:
antidepressants, Eli Lilly, Forest Labs, Pfizer
Cubist plans late-stage studies of diarrhea drug
Yahoo/AP
Friday, September 30, 2011 - 11:00am
tags:
Cubist, diarrhea, CB-183, 315, Clostridium Difficile
Cephalon gets Provigil, Nuvigil marketing subpoena
Yahoo/AP
Friday, September 30, 2011 - 10:56am
tags:
Cephalon, Provigil, NUVIGIL, subpoena, Teva Pharmaceuticals
Antares Scores Key Patent Possibly Linked To TEVA's Copaxone
Seeking Alpha
Friday, September 30, 2011 - 10:55am
tags:
Antares, patents, Teva Pharmaceuticals, Copaxone, MS, multiple sclerosis
Torrent Pharma Gets FDA Tentative Approval for Memantine Pill
Bloomberg
Friday, September 30, 2011 - 10:54am
tags:
Torrent Pharmaceuticals, FDA, memantine, generics, Namenda, Forest Labs, Alzheimer's disease
Axis-Shield Possible Bidder Backs Away as Alere Raises Stake
Bloomberg
Friday, September 30, 2011 - 10:52am
tags:
Axis-Shield, M&A, Alere, diagnostics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.